JAZZ — Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Every disclosed congressional transaction in this security, both parties, every chamber. Each row links to the filing it came from.
These are legally required disclosures, not allegations — timing can be coincidence.
Who trades it, and which way
By party
Democrats 4 Republicans 1
By direction
Purchases 3 Sales 2
Inside its sector Pharmaceuticals & Biotech
Congressional transactions per security in this sector — the page you are on is highlighted.
Plus 1,066 transactions across the sector's other securities.
Follow the federal money
Why a company's stock can be sensitive to what Congress does: many of them are also paid by the government. Jazz Pharmaceuticals plc's federal contracts, grants and loans are public record.
Look up Jazz Pharmaceuticals plc on USASpending →
We link to the source rather than repeat a dollar figure here. Federal awards are recorded under many recipient names — a parent company and its subsidiaries — so an accurate company-wide total has to be read at USASpending itself, where the recipient hierarchy is resolved. Present this beside the trading record and draw your own conclusions.
Transactions
| Date | Member | Action | Amount (as filed) | Owner | Filing |
|---|---|---|---|---|---|
| 2023-07-12 | Daniel S. Goldman D-NY | sell | $15,001 – $50,000 | self | record |
| 2023-03-06 | Daniel S. Goldman D-NY | buy | $15,001 – $50,000 | self | record |
| 2023-01-31 | Daniel S. Goldman D-NY | sell | $1,001 – $15,000 | self | record |
| 2021-10-19 | Thomas R. Suozzi D-NY | buy | $1,001 – $15,000 | self | record |
| 2019-07-15 | Bill Flores R-TX | buy | $15,001 – $50,000 | self | record |
Prices are market data (split- and dividend-adjusted closes), used only for context — every disclosure fact on this page comes from the filings linked in the table above. See Methodology.